Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 80, No. 2, 2015
Issue release date: August 2015
Section title: Novel Insights from Clinical Practice
Gynecol Obstet Invest 2015;80:139-144
(DOI:10.1159/000368231)

Management of Ovarian Cancer in 14th Gestational Week of Pregnancy by Robotic Approach with Preservation of the Fetus

Chen C.-H.a, b · Chiu L.-H.a · Chan C.a · Liu W.-M.a, b
Department of Obstetrics and Gynecology, aTaipei Medical University Hospital and bSchool of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
email Corresponding Author

Dr. Wei-Min Liu

Department of Obstetrics and Gynecology

Taipei Medical University Hospital and Taipei Medical University

No. 252, Wu-Hsing St., Sinyi District, Taipei 11031 (Taiwan)

E-Mail weimin@tmu.edu.tw

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Abstract

The objective of this study is to present a rare case of pregnancy complicated with ovarian cancer managed by robotic surgery. A 36-year-old woman suffered from sudden onset of lower abdominal pain during her pregnancy at 14 weeks of gestation. As malignancy was highly suspected, left salpingo-oophorectomy, bilateral pelvic lymph node dissection, and omentectomy were performed by robotic approach. The uterus and fetus were preserved. After surgery, 5 courses of carboplatin and paclitaxel were given, and the patient was delivered by cesarean section at 37 weeks of pregnancy. Follow-up at 18 months showed no signs of cancer recurrence. As there is limited report of pregnancy complicated with ovarian cancer managed by robotic surgery, we provide this rare case and suggest that surgical staging for ovarian malignancy can be safely accomplished by robotic approach at 14 weeks of pregnancy.

© 2015 S. Karger AG, Basel


Article / Publication Details

First-Page Preview
Abstract of Novel Insights from Clinical Practice

Published online: April 08, 2015

Number of Print Pages: 6
Number of Figures: 3
Number of Tables: 0

ISSN: 0378-7346 (Print)
eISSN: 1423-002X (Online)

For additional information: http://www.karger.com/GOI


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.